Hi-Tech Formulations Private Limited

Hi-Tech Formulations Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24232CH2002PTC025430 Incorporated 17 September 2002 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹105.6 Cr
▼ 16% YoY
Net profit · FY 2025
₹5.79 Cr
Net margin 5.5%
EBITDA · FY 2025
₹10.45 Cr
EBITDA margin 9.9%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1.07 Cr
Issued & subscribed
Open charges
₹24 Cr
Satisfied ₹22.56 Cr
Company age
24 yrs
Est. 2002
Employees · EPFO
66
Provident fund records

About Hi-Tech Formulations Private Limited

Data last updated:

Hi-Tech Formulations Private Limited is a private limited company based in Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 September 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2002PTC025430. Its GSTIN is 04AABCH6246H1ZS (Chandigarh). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.07 Cr. It is led by directors Jaspreet Singh Gulati and Dharmender Singh Gulati.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 348 Industrial Area Phase 1, Chandigarh, India – 160002.

As per the financials filed for FY 2025, the company reported a revenue of ₹105.6 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹5.79 Cr (net margin 5.5%) and EBITDA of ₹10.45 Cr (EBITDA margin 9.9%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 27% over five years.

The company has about 66 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Hitech Formulations. As per MCA filings, the company has open charges of ₹24 Cr and satisfied charges of ₹22.56 Cr on record. Court records list 2 cases involving the company. The company has 5 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹90 Lakh; the latest was in August 2023. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Unimed Technologies Limited. with revenue of ₹107.74 Cr. The company has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 228 overdue payments to 17 micro and small suppliers.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hitechformulations.com.

Company Details of Hi-Tech Formulations Private Limited
CIN U24232CH2002PTC025430
Registration Number 025430
Incorporation Date 17 September 2002
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Jaspreet Singh Gulati Director Dharmender Singh Gulati Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    hitechformulations.com
  • Social Media
    Locked
  • Registered Address
    Plot No. 348 Industrial Area Phase 1, Chandigarh, India – 160002
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Hi-Tech Formulations Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Hi-Tech Formulations Private Limited report

Financials, compliance, directors, charges, ownership and filings for Hi-Tech Formulations Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Business Activity of Hi-Tech Formulations Private Limited

The main business activity of Hi-Tech Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Hi-Tech Formulations Private Limited FY 2025 filings available

Hi-Tech Formulations Private Limited reported revenue of ₹105.6 Cr (down 16% YoY) for FY 2025.

Revenue · FY 2025
₹105.6 Cr ▼ 16%
Net profit · FY 2025
₹5.79 Cr margin 5.5%
EBITDA · FY 2025
₹10.45 Cr margin 9.9%

Compounded Annual Growth Rate (CAGR) of Hi-Tech Formulations Private Limited

Revenue CAGR growth
1 year
▼ 16%
3 years · compounded
▲ 5%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▼ 43%
3 years · compounded
▼ 16%
5 years · compounded
▲ 23%

Revenue fell 16% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 27%. EBITDA fell 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Hi-Tech Formulations Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹10.45 Cr••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)₹5.79 Cr••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Hi-Tech Formulations Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin9.9%••••••••••••••••
Net Profit Margin5.5%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hi-Tech Formulations are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Peer Comparison of Hi-Tech Formulations Private Limited

Hi-Tech Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Unimed Technologies Limited.₹107.74 Cr (FY 2025)••••••••11.0%••••Vadodara, Gujarat, India
Shivalik Remedies Private Limited₹107.31 Cr (FY 2025)••••••••11.0%••••New Delhi, Delhi, India
Genetek Lifesciences Private Limited₹107.01 Cr (FY 2024)••••••••18.0%••••Nagpur, Maharashtra, India
Chemo India Formulation Private Limited₹106.58 Cr (FY 2025)••••••••21.0%••••Hyderabad, Telangana, India
Venor Pharma Limited₹106.47 Cr (FY 2025)••••••••-16.0%••••Delhi, India
Hi-Tech Formulations Private Limited this company₹105.6 Cr (FY 2025)••••••••-16.0%••••Chandigarh, India
Mediforce Healthcare Private Limited₹105.22 Cr (FY 2024)••••••••22.0%••••Meerut, Uttar Pradesh, India
Sara Exports Limited₹104.97 Cr (FY 2024)••••••••-66.0%••••New Delhi, Delhi, India
Suresh Pharmaceuticals Private Limited₹104.87 Cr (FY 2024)••••••••19.0%••••Chennai, Tamil Nadu, India
Suraksha Pharma Private Limited₹103.85 Cr (FY 2025)••••••••24.0%••••Hyderabad, Telangana, India
Sirmaxo Chemicals Pvt Ltd₹103.62 Cr (FY 2025)••••••••6.0%••••Mumbai, Maharashtra, India

Peers are the five companies nearest above and the five nearest below Hi-Tech Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Hi-Tech Formulations Private Limited

Hi-Tech Formulations Private Limited is audited by Gambhir Khurana & Associates for the financial year 2023.

NameStatusAppointment DateCessation Date
Gambhir Khurana & AssociatesLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Hi-Tech Formulations Private Limited

Hi-Tech Formulations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jaspreet Singh Gulati
Also directs: Quencil Research Private Limited, Lyra Laboratories Private Limited
Director21 Dec 201411 Years 9 MonthsCurrent
Dharmender Singh Gulati
Also directs: Quencil Research Private Limited, Re'equil India Private Limited, Lyra Laboratories Private Limited and 2 more
Director17 Sep 200224 Years 1 MonthsCurrent
View all directors

Ownership and Shareholding of Hi-Tech Formulations Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Hi-Tech Formulations Private Limited

Open charges
₹24 Cr
Satisfied charges
₹22.56 Cr
Breakdown by lending institutions
Bank of India₹24.00 Cr
Latest charge details
DateLenderAmountStatus
02 Aug 2025Bank of India₹24 CrOpen
26 Jun 2024Hdfc Bank Limited₹30.98 LakhSatisfied
21 Nov 2022Hdfc Bank Limited₹80 LakhSatisfied
25 Oct 2018Hdfc Bank Limited₹13 CrSatisfied
07 Oct 2015Others₹7.7 CrSatisfied

Total charge records: 8 View all charges

Deals & Funding of Hi-Tech Formulations Private Limited

Hi-Tech Formulations Private Limited has 5 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹90 Lakh; the latest was in August 2023.

Total deals
5
Secondary share transfers
3
Rights issue
1
Funding round
1
Disclosed funding
₹90 Lakh

Deals on record (5 of 5)

WhenDealAmountParties
Aug 2023Secondary share transferUndisclosedSeller: 2 individuals
Mar 2022Secondary share transferUndisclosedSeller: 2 individuals
Sep 2016Funding round₹90 LakhInvestors: 2 individuals
Aug 2015Rights issue₹99 LakhInvestors: 2 individuals
May 2015Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Premium access

Full deal history

All 5 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME Payment Delays by Hi-Tech Formulations Private Limited

Hi-Tech Formulations Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 228 overdue payments to 17 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 17)

SupplierAmount dueDue sinceReported on
Jasco Paper Products••••••••••••
Kap Lamipack••••••••••••
Waxoils Private Limited••••••••••••
Gangwal Chemicals Pvt Ltd••••••••••••
Shreyas Cartons Private Limited••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Associated Brands with Hi-Tech Formulations Private Limited

Hi-Tech Formulations operates one associated brand: Hitech Formulations. Each brand links to its own profile.

BrandDescriptionWebsite
Hitech Formulations
Skin care products are distributed via an internet-first brand.hitechformulations.com

Employees and EPFO Compliance at Hi-Tech Formulations Private Limited

Hi-Tech Formulations Private Limited has a workforce of 66 employees as of Mar 23, 2024.

Employee count
66
Active EPFO establishments
1
Employee growth
34.69%
Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Hi-Tech Formulations Private Limited

Hi-Tech Formulations Private Limited has 4 board changes on record since 2002: 2 appointments and 2 cessations. The latest: Jaspreet Singh Gulati ceased to be Additional Director on 30 Sep 2015.

Charges
A charge registered on 25 Oct 2018 via Charge ID 100235198 with Hdfc Bank Limited was fully satisfied on 03 Dec 2025.
AGM
Hi-Tech Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 26 Jun 2024 via Charge ID 100941337 with Hdfc Bank Limited was fully satisfied on 06 Aug 2025.
Charges
A charge registered on 21 Nov 2022 via Charge ID 100665808 with Hdfc Bank Limited was fully satisfied on 06 Aug 2025.
Charges
A charge with Bank Of India amounted to Rs. 24.00 Cr with Charge ID 101151741 was registered on 02 Aug 2025.
Filing
Hi-Tech Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Charges
A charge with Hdfc Bank Limited of Rs. 13.00 Cr registered on 25 Oct 2018 with Charge ID 100235198 was modified on 28 Aug 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.31 Cr with Charge ID 100941337 was registered on 26 Jun 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.80 Cr with Charge ID 100665808 was registered on 21 Nov 2022.
Charges
A charge registered on 07 Oct 2015 via Charge ID 10600295 with Others was fully satisfied on 29 Nov 2018.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.00 Cr with Charge ID 100235198 was registered on 25 Oct 2018.
Charges
A charge with Others of Rs. 7.70 Cr registered on 07 Oct 2015 with Charge ID 10600295 was modified on 18 Jan 2018.

12 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Hi-Tech Formulations Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Hi-Tech Formulations Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Hi-Tech Formulations Private Limited

Hi-Tech Formulations has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
04AABCH6246H1ZSChandigarhActive31 Oct 2020
02AABCH6246H1ZWHimachal PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Hi-Tech Formulations Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Related news about Hi-Tech Formulations Private Limited

Frequently Asked Questions about Hi-Tech Formulations Private Limited

Hi-Tech Formulations is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 September 2002 (24+ years old) and is registered under CIN U24232CH2002PTC025430.

Hi-Tech Formulations reported revenue of ₹105.6 Cr for FY 2025 (down 16% YoY).

Hi-Tech Formulations has 2 current directors:

Hi-Tech Formulations reported a net profit of ₹5.79 Cr (net margin 5.5%) and EBITDA of ₹10.45 Cr (EBITDA margin 9.9%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Hi-Tech Formulations is 5% over three years and 27% over five years. In the latest year (FY 2025) revenue fell 16%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Hi-Tech Formulations is 04AABCH6246H1ZS, registered in Chandigarh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AABCH6246H1ZW (Himachal Pradesh).

The CIN (Corporate Identification Number) of Hi-Tech Formulations is U24232CH2002PTC025430. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Hi-Tech Formulations has 2 court cases on record.

Hi-Tech Formulations was incorporated on 17 September 2002, making it 24+ years old. It is registered with the Registrar of Companies, Chandigarh.

Hi-Tech Formulations has 5 deals on record (3 secondary share transfers, 1 rights issue, 1 funding round), with disclosed funding of ₹90 Lakh; the latest was in August 2023.

The peers of Hi-Tech Formulations by revenue are Unimed Technologies Limited, Shivalik Remedies Private Limited, Genetek Lifesciences Private Limited, Chemo India Formulation Private Limited, Venor Pharma Limited and 5 more, all in the Pharma industry (Formulations).

Jaspreet Singh Gulati ceased to be Additional Director on 30 Sep 2015. Gurvinder Kaur ceased to be Director on 21 Dec 2014. Jaspreet Singh Gulati was appointed as Director on 21 Dec 2014. Hi-Tech Formulations has 4 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available